Bridgebio Pharma Inc (BBIO)

Total Costs & Expenses

$350.76M

Quarterly · Period ending: · USD

BBIO logo

BBIO Total Costs & Expenses

Latest reported$350.76M
BBIO Quarterly Total Costs & Expenses ($41.84M → $350.76M)
High-resolution chart · PNG

BBIO total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
350,755,000
300,471,000
339,418,000
265,899,000
244,843,000
221,005,000
231,909,000
194,482,000
177,707,000
210,777,000
179,161,000
161,783,000
147,740,000
127,989,000
131,102,000
129,454,000
153,922,000
175,372,000
178,500,000
151,843,000
148,039,000
167,966,000
127,611,000
128,066,000
124,567,000
102,487,000
92,457,000
81,273,000
69,318,000
63,752,000
65,583,000
41,456,000
34,783,000
41,838,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.